Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0129914 Aminosteroids for the Treatment of a PTP1B Associated Disease
This application is directed to the use of aminosteroid compounds for the selective inhibition of the enzyme PTP1B in a mammal for the treatment of diabetes.
2017/0129913 CRYSTALLINE MICROPOROUS MATERIAL MEDIATED CONVERSION OF C1-3 OXYGENATE COMPOUNDS TO C4 OXYGENATE COMPOUNDS
A process for the preparation of C.sub.4 oxygenate compounds such as threose, erythrose or erythrulose starting from a composition comprising C.sub.1-3...
2017/0129912 ALKOXIDE COMPOUND, THIN FILM-FORMING STARTING MATERIAL, THIN FILM FORMATION METHOD, AND ALCOHOL COMPOUND
The alkoxide compound of the present invention is characteristically represented by the following general formula (I): ##STR00001##
2017/0129911 COMPLEXES COMPRISING A PLATINUM COMPOUND AND AN IMMUNE CHECKPOINT INHIBITOR AND RELATED METHODS
Complexes comprising a platinum compound and an immune checkpoint inhibitor, and related methods, are generally provided. In some embodiments, the immune...
2017/0129910 Z-SELECTIVE RING-CLOSING METATHESIS REACTIONS
The present invention relates generally to olefin metathesis. In some embodiments, the present invention provides methods for Z-selective ring-closing metathesis.
2017/0129909 SPIROCYCLIC ARYL PHOSPHORUS OXIDE AND ARYL PHOSPHORUS SULFIDE
Disclosed is a spirocyclic aryl phosphorus oxide or sulfide as an ALK inhibitor, particularly, a compound represented by formula (I) as an ALK inhibitor or...
2017/0129908 DIAMINOSILANE COMPOUNDS
Disclosed is a compound of formula (I): (R.sup.1 R.sup.2N)Si.sub.nH.sub.2n(NR.sup.3R.sup.4) (I) wherein subscript n, R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are...
2017/0129907 NANOPARTICLES CONTAINING AZOLIUM AND N-HETEROCYCLIC CARBENE COMPOUNDS AND USE THEREOF
The present application provides a composition comprising a core formed by gold nanoparticle, a compound of Formula (I): ##STR00001## wherein dashed lines in...
2017/0129906 REACTIONS OF THIADIAZOLYL-OXIMINOACETIC ACID DERIVATIVE COMPOUNDS
This disclosure relates to an improved synthesis of cephalosporin antibiotic compounds such as ceftolozane, and compositions and methods of use thereof....
2017/0129905 Fused Bicyclic Heteroaromatic Derivatives as Kinase Inhibitors
A series of fused bicyclic heteroaromatic derivatives of formula (IA) or (IB), as defined herein, being selective inhibitors of phosphatidylinositol-4-kinase...
2017/0129904 NEW COMPOUND FOR INHIBITING BINDING BETWEEN DX2 PROTEIN AND P14/ARF PROTEIN, AND PHARMACEUTICAL COMPOSITION FOR...
Disclosed is a new compound that inhibits binding between a DX2 protein and a p14/ARF protein, a pharmaceutical composition including the new compound as an...
2017/0129903 COMPOUNDS COMPRISING 1,1a,2,5a-TETRAHYDROSPIRO[INDOLE-3,2a-PYRROLE]-2,5a-DIONE SYSTEM AS INHIBITORS...
A spirooxoindole compound represented by the formula selected from the group consisting of formula (IA) and (IB), wherein all symbols are as defined in the...
2017/0129902 PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-alpha]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2- ...
The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-- ...
2017/0129901 Disubstituted Octahydropyrrolo[3,4-C]Pyrroles As Orexin Receptor Modulators
Disubstituted octahydropyrrolo[3,4-c]pyrrole compounds are described, which are useful as orexin receptor modulators. Such compounds may be useful in...
2017/0129900 Crystalline Forms Of Pemetrexed Diacid And Processes For The Preparation Thereof
Provided are crystalline forms of N-[4-[2-(2-amino-4, 7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]ben-zoyl]-L-glutami- c acid, pemetrexed diacid, and...
2017/0129899 HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS
This application relates to compounds of Formula (I): ##STR00001## or pharmaceutically acceptable salts or stereoisomers thereof, which are inhibitors of...
2017/0129898 PROCESS FOR THE PREPARATION OF TRIAZOLO[4,5-D] PYRIMIDINE CYCLOPENTANE COMPOUNDS
The present invention relates to a process for preparation of triazolo[4,5-d] pyrimidine cyclopentane compounds of formula (I), and pharmaceutically acceptable...
2017/0129897 Pyrazolopyrimidine Derivatives Useful as Inhibitors of Bruton's Tyrosine Kinase
This invention relates to compounds of formula (I). The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention...
2017/0129896 PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE
Pyrazolo[1,5-a]pyrimidine-based compounds of the formula: ##STR00001## are disclosed, wherein R.sub.1, R.sub.2 and R.sub.3 are defined herein. Compositions...
2017/0129895 AMORPHOUS FORM OF BARICITINIB
The present invention provides an amorphous form of baricitinib, processes for its preparation, a pharmaceutical composition comprising it, and its use for the...
2017/0129894 Triazolopyridazine Derivatives as Modulators of TNF Activity
A series of substituted [1,2,4]triazolo[4,3-b]pyridazine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit...
2017/0129893 Novel Crystalline Form of Levomefolate
The present disclosure relates to crystalline forms of levomefolate calcium). The present disclosure also relates to a process for the preparation of...
2017/0129892 TRICYCLIC COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands...
2017/0129891 SUBSTITUTED IMIDAZOQUINOLINES, IMIDAZOPYRIDINES, AND IMIDAZONAPHTHYRIDINES
Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, [1,5]naphthyridines,...
2017/0129890 TYROSINE KINASE INHIBITORS
The present disclosure provides compounds that are tyrosine kinase inhibitors, in particular Bruton tyrosine kinase ("BTK") inhibitors, and are therefore...
2017/0129889 SUBSTITUTED 2-(4-HETEROCYCLYLBENZYL)ISOINDOLIN-1-ONE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF THE...
In one aspect, the invention relates to substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs compounds, derivatives thereof, and related compounds,...
2017/0129888 PYRIDINO[1,2-A]PYRIMIDONE ANALOGUE USED AS MTOR/P13K INHIBITOR
Disclosed is a pyridino[1,2-a]pyrimidone analogue used as an mTOR/PI3K inhibitor. The present invention particularly relates to a compound represented by...
2017/0129887 NITROGENATED HETEROCYCLIC COMPOUND
The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of...
2017/0129886 MYOSIN II ATPASE INHIBITOR COMPOUNDS
The present invention relates to Myosin II ATPase inhibitor compounds, including substituted 3a-hydroxy-1, 2, 3, 3a-tetrahydro-4H-pyrrolo [2,3b] quinolin-4-one...
2017/0129885 COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY
Provided herein are compounds, compositions thereof and uses therewith for treating spinal muscular atrophy.
2017/0129884 AZAINDOLE ACETIC ACID DERIVATIVES AND THEIR USE AS PROSTAGLANDIN D2 RECEPTOR MODULATORS
The present invention relates to azaindole acetic acid derivatives of formula (I), ##STR00001## wherein R.sup.1 and R.sup.2 are as described in the description...
2017/0129883 Tetrahydroimidazopyridine Derivatives as Modulators of TNF Activity
A series of substituted 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine derivatives, being potent treatment and/or prevention of various human ailments, including...
2017/0129882 INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic...
2017/0129881 TRPM8 ANTAGONISTS
The invention relates to compounds acting as selective antagonists of Transient Receptor Potential cation channel subfamily M member 8 (TRPM8), and having...
2017/0129880 FACTOR IXa INHIBITORS
In its many embodiments, the present invention provides a novel class of benzamide compounds represented by Formula (I) or pharmaceutically acceptable salts or...
2017/0129879 4-SUBSTITUTED-2-(5-SUBSTITUTED-1H-INDOL-2-YL)PHENOL DERIVATIVES, METHODS FOR PREPARING THE PHENOL DERIVATIVES...
Disclosed are 4-substituted-2-(5-substituted-1H-indol-2-yl)phenol derivatives for controlling the proliferation and migration of kinase-overexpressed cells....
2017/0129878 BENZISOXAZOLES
The present invention relates to novel fatty acid esters of the reversible Iloperidone metabolite P-88-8991, their preparation, their use as pharmaceuticals...
2017/0129877 Cyclic Amine Azaheterocyclic Carboxamides
The invention provides novel cyclic amine azaheterocyclic carboxamide according to Formula (I), Formula (II) and Formula (III) their manufacture and use for...
2017/0129876 UREA DERIVATIVES AND USES THEREOF
The present invention provides novel compounds of any one of Formulae (I)-(III), and pharmaceutical compositions thereof. Also provided are particles (e.g.,...
2017/0129874 NOVEL IMPROVED PROCESS FOR PREPARING A TRIAZOLE ANTIFUNGAL AGENT
An improved process for the preparation of Efinaconazole of Formula (I) or its salts may include reacting triazole compound of Formula (III) or its salts with...
2017/0129873 6-, 7-, OR 8-SUBSTITUTED QUINAZOLINONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME
Provided are quinazolinone compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and...
2017/0129872 PROCESS FOR THE PREPARATION OF CHIRAL 8-(3-AMINOPIPERIDIN-1-YL)-XANTHINES
The invention relates to an improved process for preparing enantiomerically pure 8-(3-aminopiperidin-1-yl)-xanthines.
2017/0129871 COMPOSITIONS COMPRISING AN INHIBITOR OF LYSINE SPECIFIC DEMETHYLASE-1
Described herein are amorphous and crystalline forms of pharmaceutically acceptable salts of the lysine specific demethylase-1 inhibitor ...
2017/0129870 COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISEASES
The compositions and compounds of Formula I which includes a salt of duloxetine or its polymorphs, enantiomers, stereoisomers, solvates, and hydrates thereof....
2017/0129869 AMORPHOUS FORM OF ELIGLUSTAT HEMITARTARATE
The present application relates to the solid state forms of Eliglustat hemitartrate and the processes for the preparation thereof. The application further...
2017/0129868 TRIENTINE PRODRUGS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE
Trientine prodrugs, pharmaceutical compositions comprising the trientine prodrugs, and methods of using trientine prodrugs and pharmaceutical compositions...
2017/0129867 TIOPRONIN PRODRUGS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE
Tiopronin prodrugs, pharmaceutical compositions comprising the tiopronin prodrugs, and methods of using tiopronin prodrugs and pharmaceutical compositions...
2017/0129866 Method For Improving The Oxygen-Releasing Ability Of Hemoglobin To Organs Or Peripheral Tissues In Human Bodies...
A method for improving the oxygen-releasing ability of hemoglobin, hemoglobin variants, recombinant hemoglobin or hemoglobin-based blood substitutes to organs...
2017/0129865 STEREO CONTROLLED SYNTHESIS OF (E,Z)-DIENALS VIA TANDEM RH(I) CATALYZED PROPARGYL CLAISEN REARRANGEMENT
A novel Rh(I)-catalyzed approach to synthesizing functionalized (E,Z) dienal compounds has been developed via tandem transformation where a stereoselective...
2017/0129864 NEW SIGMA-RECEPTORS LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES, OVER CELLULAR BIOCHEMICAL...
The present invention involves new and original sigma receptors ligands: (Mono-or di-alkylaminoalkyl)-.gamma.-butyrolactones, their analogues ...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.